Immunological profile of patients awaiting a renal transplant

Clinical Transplantation
Inmaculada DíazFrancisco Valdés

Abstract

A renal transplant is the best possible treatment for patients with terminal renal failure. Advances in the development of techniques of screening of pre-formed antibodies have contributed to a notable improvement in the results obtained with allogenic transplants. The aim of the present work is to study the nature, class, isotype and specificity of antibodies detected in patients awaiting renal transplantation at Complejo Hospitalario Universitario Juan Canalejo, as well as their relation with the level of anti-human leucocyte antigen (HLA) sensitization. In all patient groups, there was a predominance of IgG. The distribution of anti-HLA antibody class showed that the most frequent pattern corresponded to a mixture of class I and class II antibodies for all groups. The study of specificity of anti-HLA antibody showed that of the patients with at least one previous transplant, 72% developed specific anti-HLA antibodies against some of the incompatible antigens of the donor, 12% against HLA antigens not related with the phenotype of the donor and in 16% it was not possible to determine their specificity. Most patients developed antibodies against antigens of locus B, probably because of that the number of incompatibilities cont...Continue Reading

References

Jan 1, 1974·Vox Sanguinis·B Pirofsky, E R Rosner
Mar 20, 1999·Transplantation Proceedings·P C RodríguezL F García
May 8, 2000·Transplantation·H M Gebel, R A Bray
May 1, 2002·Transplantation·Caner Süsal, Gerhard Opelz

❮ Previous
Next ❯

Citations

Nov 18, 2008·Transplantation Proceedings·J PéfaurL Contreras

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Nature Reviews. Immunology
R B Colvin, R Neal Smith
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Paul I Terasaki
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Paul I Terasaki, Miyuki Ozawa
© 2021 Meta ULC. All rights reserved